Cargando…
Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study
BACKGROUND: Sepsis leads to high mortality, therefore risk stratification is important. The abbMEDS (abbreviated Mortality Emergency Department Sepsis) score assesses sepsis severity and predicts mortality. In community-acquired pneumonia, the CURB-65 (Confusion, Urea, Respiration, Blood pressure, A...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605126/ https://www.ncbi.nlm.nih.gov/pubmed/26464225 http://dx.doi.org/10.1186/s12873-015-0056-z |
_version_ | 1782395168048021504 |
---|---|
author | Roest, Asselina A. Tegtmeier, Jan Heyligen, Joris J. Duijst, Jeanette Peeters, Andrea Borggreve, Hella F. Lashof, Astrid ML Oude Stehouwer, Coen DA Stassen, Patricia M. |
author_facet | Roest, Asselina A. Tegtmeier, Jan Heyligen, Joris J. Duijst, Jeanette Peeters, Andrea Borggreve, Hella F. Lashof, Astrid ML Oude Stehouwer, Coen DA Stassen, Patricia M. |
author_sort | Roest, Asselina A. |
collection | PubMed |
description | BACKGROUND: Sepsis leads to high mortality, therefore risk stratification is important. The abbMEDS (abbreviated Mortality Emergency Department Sepsis) score assesses sepsis severity and predicts mortality. In community-acquired pneumonia, the CURB-65 (Confusion, Urea, Respiration, Blood pressure, Age) also provides support in clinical decisions regarding antibiotic treatment and clinical disposition. We investigated the predictive value and feasibility of the abbMEDS and CURB-65 in sepsis patients at the ED and the relationship between the scores and antibiotic treatment and clinical disposition (i.e. admission and type of ward). METHODS: In this retrospective cohort study, we included 725 sepsis patients at the ED. We investigated the value in predicting 28-day mortality and feasibility of both scores. We calibrated the abbMEDS. We further assessed the relationship between the three risk categories per score and antibiotic treatment (i.e. oral and intravenous narrow or broad-spectrum) and clinical disposition. RESULTS: Both abbMEDS and CURB-65 were good predictors of 28-day mortality (13.0 %) (AUC 0.77 [95 % CI 0.72 – 0.83] and 0.73 [95 % CI 0.67 - 0.78], respectively) and feasible (complete score 92.7 and 93.9 %, respectively). In the high risk category of the abbMEDS, all patients were admitted and treated with intravenous broad-spectrum antibiotics. In the high risk category of the CURB-65, 2.5 % were not admitted and 4.4 % received no antibiotics. CONCLUSION: Both abbMEDS and CURB-65 are good predictors of 28-day mortality in septic ED patients. The abbMEDS is well calibrated and matches current clinical decisions concerning antibiotic treatment and clinical disposition, while this is less so for the CURB-65. In the future, use of the abbMEDS at the ED may improve sepsis care when its value as a decision support tool can be confirmed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12873-015-0056-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4605126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46051262015-10-15 Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study Roest, Asselina A. Tegtmeier, Jan Heyligen, Joris J. Duijst, Jeanette Peeters, Andrea Borggreve, Hella F. Lashof, Astrid ML Oude Stehouwer, Coen DA Stassen, Patricia M. BMC Emerg Med Research Article BACKGROUND: Sepsis leads to high mortality, therefore risk stratification is important. The abbMEDS (abbreviated Mortality Emergency Department Sepsis) score assesses sepsis severity and predicts mortality. In community-acquired pneumonia, the CURB-65 (Confusion, Urea, Respiration, Blood pressure, Age) also provides support in clinical decisions regarding antibiotic treatment and clinical disposition. We investigated the predictive value and feasibility of the abbMEDS and CURB-65 in sepsis patients at the ED and the relationship between the scores and antibiotic treatment and clinical disposition (i.e. admission and type of ward). METHODS: In this retrospective cohort study, we included 725 sepsis patients at the ED. We investigated the value in predicting 28-day mortality and feasibility of both scores. We calibrated the abbMEDS. We further assessed the relationship between the three risk categories per score and antibiotic treatment (i.e. oral and intravenous narrow or broad-spectrum) and clinical disposition. RESULTS: Both abbMEDS and CURB-65 were good predictors of 28-day mortality (13.0 %) (AUC 0.77 [95 % CI 0.72 – 0.83] and 0.73 [95 % CI 0.67 - 0.78], respectively) and feasible (complete score 92.7 and 93.9 %, respectively). In the high risk category of the abbMEDS, all patients were admitted and treated with intravenous broad-spectrum antibiotics. In the high risk category of the CURB-65, 2.5 % were not admitted and 4.4 % received no antibiotics. CONCLUSION: Both abbMEDS and CURB-65 are good predictors of 28-day mortality in septic ED patients. The abbMEDS is well calibrated and matches current clinical decisions concerning antibiotic treatment and clinical disposition, while this is less so for the CURB-65. In the future, use of the abbMEDS at the ED may improve sepsis care when its value as a decision support tool can be confirmed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12873-015-0056-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-13 /pmc/articles/PMC4605126/ /pubmed/26464225 http://dx.doi.org/10.1186/s12873-015-0056-z Text en © Roest et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Roest, Asselina A. Tegtmeier, Jan Heyligen, Joris J. Duijst, Jeanette Peeters, Andrea Borggreve, Hella F. Lashof, Astrid ML Oude Stehouwer, Coen DA Stassen, Patricia M. Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study |
title | Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study |
title_full | Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study |
title_fullStr | Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study |
title_full_unstemmed | Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study |
title_short | Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study |
title_sort | risk stratification by abbmeds and curb-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605126/ https://www.ncbi.nlm.nih.gov/pubmed/26464225 http://dx.doi.org/10.1186/s12873-015-0056-z |
work_keys_str_mv | AT roestasselinaa riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT tegtmeierjan riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT heyligenjorisj riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT duijstjeanette riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT peetersandrea riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT borggrevehellaf riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT lashofastridmloude riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT stehouwercoenda riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy AT stassenpatriciam riskstratificationbyabbmedsandcurb65inrelationtotreatmentandclinicaldispositionofthesepticpatientattheemergencydepartmentacohortstudy |